Literature DB >> 33115869

Capsid Lattice Destabilization Leads to Premature Loss of the Viral Genome and Integrase Enzyme during HIV-1 Infection.

Jenna E Eschbach1, Jennifer L Elliott1, Wen Li2,3, Kaneil K Zadrozny4, Keanu Davis1, Shawn J Mohammed1, Dana Q Lawson1, Owen Pornillos4, Alan N Engelman2,3, Sebla B Kutluay5.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) capsid (CA) protein forms a conical lattice around the viral ribonucleoprotein complex (vRNP) consisting of a dimeric viral genome and associated proteins, together constituting the viral core. Upon entry into target cells, the viral core undergoes a process termed uncoating, during which CA molecules are shed from the lattice. Although the timing and degree of uncoating are important for reverse transcription and integration, the molecular basis of this phenomenon remains unclear. Using complementary approaches, we assessed the impact of core destabilization on the intrinsic stability of the CA lattice in vitro and fates of viral core components in infected cells. We found that substitutions in CA can impact the intrinsic stability of the CA lattice in vitro in the absence of vRNPs, which mirrored findings from an assessment of CA stability in virions. Altering CA stability tended to increase the propensity to form morphologically aberrant particles, in which the vRNPs were mislocalized between the CA lattice and the viral lipid envelope. Importantly, destabilization of the CA lattice led to premature dissociation of CA from vRNPs in target cells, which was accompanied by proteasomal-independent losses of the viral genome and integrase enzyme. Overall, our studies show that the CA lattice protects the vRNP from untimely degradation in target cells and provide the mechanistic basis of how CA stability influences reverse transcription.IMPORTANCE The human immunodeficiency virus type 1 (HIV-1) capsid (CA) protein forms a conical lattice around the viral RNA genome and the associated viral enzymes and proteins, together constituting the viral core. Upon infection of a new cell, viral cores are released into the cytoplasm where they undergo a process termed "uncoating," i.e., shedding of CA molecules from the conical lattice. Although proper and timely uncoating has been shown to be important for reverse transcription, the molecular mechanisms that link these two events remain poorly understood. In this study, we show that destabilization of the CA lattice leads to premature dissociation of CA from viral cores, which exposes the viral genome and the integrase enzyme for degradation in target cells. Thus, our studies demonstrate that the CA lattice protects the viral ribonucleoprotein complexes from untimely degradation in target cells and provide the first causal link between how CA stability affects reverse transcription.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  HIV-1; RNA degradation; capsid; core; reverse transcription; uncoating

Mesh:

Substances:

Year:  2020        PMID: 33115869      PMCID: PMC7944438          DOI: 10.1128/JVI.00984-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  145 in total

Review 1.  HIV-1 capsid: the multifaceted key player in HIV-1 infection.

Authors:  Edward M Campbell; Thomas J Hope
Journal:  Nat Rev Microbiol       Date:  2015-08       Impact factor: 60.633

2.  Early cytoplasmic uncoating is associated with infectivity of HIV-1.

Authors:  João I Mamede; Gianguido C Cianci; Meegan R Anderson; Thomas J Hope
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-07       Impact factor: 11.205

3.  The cyclosporin A washout assay to detect HIV-1 uncoating in infected cells.

Authors:  Amy E Hulme; Thomas J Hope
Journal:  Methods Mol Biol       Date:  2014

Review 4.  The regulation of mRNA stability in mammalian cells: 2.0.

Authors:  Xiangyue Wu; Gary Brewer
Journal:  Gene       Date:  2012-03-16       Impact factor: 3.688

5.  Host protein Ku70 binds and protects HIV-1 integrase from proteasomal degradation and is required for HIV replication.

Authors:  Yingfeng Zheng; Zhujun Ao; Binchen Wang; Kallesh Danappa Jayappa; Xiaojian Yao
Journal:  J Biol Chem       Date:  2011-03-29       Impact factor: 5.157

6.  Novel inhibitor binding site discovery on HIV-1 capsid N-terminal domain by NMR and X-ray crystallography.

Authors:  Nathalie Goudreau; Christopher T Lemke; Anne-Marie Faucher; Chantal Grand-Maître; Sylvie Goulet; Jean-Eric Lacoste; Jean Rancourt; Eric Malenfant; Jean-François Mercier; Steve Titolo; Stephen W Mason
Journal:  ACS Chem Biol       Date:  2013-03-25       Impact factor: 5.100

7.  Direct Visualization of HIV-1 Replication Intermediates Shows that Capsid and CPSF6 Modulate HIV-1 Intra-nuclear Invasion and Integration.

Authors:  Christopher R Chin; Jill M Perreira; George Savidis; Jocelyn M Portmann; Aaron M Aker; Eric M Feeley; Miles C Smith; Abraham L Brass
Journal:  Cell Rep       Date:  2015-11-12       Impact factor: 9.423

Review 8.  Revisiting HIV-1 uncoating.

Authors:  Nathalie Arhel
Journal:  Retrovirology       Date:  2010-11-17       Impact factor: 4.602

9.  Evidence for biphasic uncoating during HIV-1 infection from a novel imaging assay.

Authors:  Hongzhan Xu; Tamera Franks; Gregory Gibson; Kelly Huber; Nadia Rahm; Caterina Strambio De Castillia; Jeremy Luban; Christopher Aiken; Simon Watkins; Nicolas Sluis-Cremer; Zandrea Ambrose
Journal:  Retrovirology       Date:  2013-07-09       Impact factor: 4.602

10.  Nucleoporin NUP153 phenylalanine-glycine motifs engage a common binding pocket within the HIV-1 capsid protein to mediate lentiviral infectivity.

Authors:  Kenneth A Matreyek; Sara S Yücel; Xiang Li; Alan Engelman
Journal:  PLoS Pathog       Date:  2013-10-10       Impact factor: 6.823

View more
  7 in total

1.  Dynactin 1 negatively regulates HIV-1 infection by sequestering the host cofactor CLIP170.

Authors:  Shanmugapriya Shanmugapriya; Eveline Santos da Silva; Jackson A Campbell; Marie-Philipe Boisjoli; Mojgan H Naghavi
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-26       Impact factor: 11.205

Review 2.  Structure, Function, and Interactions of the HIV-1 Capsid Protein.

Authors:  Eric Rossi; Megan E Meuser; Camille J Cunanan; Simon Cocklin
Journal:  Life (Basel)       Date:  2021-01-29

Review 3.  Disassembling the Nature of Capsid: Biochemical, Genetic, and Imaging Approaches to Assess HIV-1 Capsid Functions.

Authors:  Zachary Ingram; Douglas K Fischer; Zandrea Ambrose
Journal:  Viruses       Date:  2021-11-07       Impact factor: 5.048

Review 4.  HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules.

Authors:  Akatsuki Saito; Masahiro Yamashita
Journal:  Retrovirology       Date:  2021-10-26       Impact factor: 4.602

5.  Selection and identification of an RNA aptamer that specifically binds the HIV-1 capsid lattice and inhibits viral replication.

Authors:  Paige R Gruenke; Rachna Aneja; Sarah Welbourn; Obiaara B Ukah; Stefan G Sarafianos; Donald H Burke; Margaret J Lange
Journal:  Nucleic Acids Res       Date:  2022-02-22       Impact factor: 19.160

Review 6.  HIV-1 capsid exploitation of the host microtubule cytoskeleton during early infection.

Authors:  Mojgan H Naghavi
Journal:  Retrovirology       Date:  2021-07-06       Impact factor: 4.602

Review 7.  The HIV-1 capsid and reverse transcription.

Authors:  Christopher Aiken; Itay Rousso
Journal:  Retrovirology       Date:  2021-09-25       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.